GENLISA™ Human SARS-CoV-2 (Covid-19) Envelope Protein Antigen Quantitative TITRATION ELISA

SKU: KBVH015-30 Category:

58,000.00

ELISA for the quantitative estimation of the SARS-CoV-2 (Covid-19) Envelope protein antigen in human serum and plasma samples.


Availability: 2 – 3 Days | Pack Size: 1 x 96 wells



Description

Introduction:
The GENLISA ELISA kits are used for assessing the specific biomarker in samples analytes which may be serum, plasma and cell culture supernatant as validated with the kit. The kit employs a sandwich ELISA technique.

Intended Use:
The GENLISA Human SARS-CoV-2 (Covid-19) Envelope Protein Antigen ELISA kit is used as an analytical tool for quantitative antigen determination of Human SARS-CoV-2 (Covid-19) Envelope Proteins in humanserum and plasma.

Principle:
The method employs sandwich ELISA technique. Standards or Samples are added to the microtiter well which is pre-coated with SARS-CoV-2 Envelope Protein antibody. Plates are washed with wash buffer to remove unbound sample. Anti- Human IgG HRP Conjugate is added to the microplate and incubated to form a complex. After incubation and a washing step TMB Substrate is added. Blue color develops on incubation and the reaction is stopped with a Stop Solution to form a yellow color. The concentration of the SARS-CoV-2 Envelope Protein in the samples is directly proportional to the yellow color developed (absorbance) in the wells. Absorbance is measured at 450 nm.









If you have published a paper by using any of our ELISA since 01/01/2023, kindly fill out the “Krishgen Publication Reward Application Form” with complete information and send it by at email: info@krishgen.com, with the subject “Krishgen Publication Reward”. We will get back to you with the Amazon / Krishgen Credit Reward after we confirm it ASAP!

View more details about our Publication Reward

Additional information

Species

Human

Sample Type

Serum and Plasma

Calibration Range

62.5 – 3000 ng/ml

Sensitivity

60 ng/ml

Detection Method

Colorimetric, 450nm

Regulatory Status

For Research Use Only

Research Area

COVID-19